Share chart Harmony Biosciences Holdings, Inc.
Extended chart
Simple chart
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., фармацевтическая компания на коммерческой стадии, специализируется на разработке и коммерциализации методов лечения пациентов с редкими неврологическими расстройствами. Его ведущий продукт включает ВАКИКС (питолизант) для лечения педиатрических пациентов, страдающих нарколепсией. Harmony Biosciences Holdings, Inc. ранее была известна как Harmony Biosciences II, Inc. и изменила свое название на Harmony Biosciences Holdings, Inc. в феврале 2020 года. Компания была основана в 2017 году и базируется в Плимуте, штат Пенсильвания.IPO date | 2020-08-19 |
---|---|
ISIN | US4131971040 |
Industry | Pharmaceuticals |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.harmonybiosciences.com |
Цена ао | 37.84 |
Change price per day: | 0% (37.84) |
---|---|
Change price per week: | -2.42% (38.78) |
Change price per month: | +3.9% (36.42) |
Change price per 3 month: | +14.67% (33) |
Change price per half year: | +3.84% (36.44) |
Change price per year: | +7.93% (35.06) |
Change price per 3 year: | -17.11% (45.65) |
Change price per 5 year: | 0% (37.84) |
Change price per 10 year: | 0% (37.84) |
Change price per year to date: | +8.99% (34.72) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Valor Management LLC | 11218033 | 19.76 |
Blackrock Inc. | 6003327 | 10.57 |
FMR, LLC | 5276825 | 9.3 |
Vanguard Group Inc | 3674764 | 6.47 |
Vivo Capital, LLC | 2606247 | 4.59 |
State Street Corporation | 1360447 | 2.4 |
Pacer Advisors, INC. | 1224910 | 2.16 |
Morgan Stanley | 1086215 | 1.91 |
venBio Partners LLC | 1035396 | 1.82 |
Camber Capital Management LP | 750000 | 1.32 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Jeffrey S. Aronin | Founder & Non-Executive Chairman | 19.6k | 1968 (57 years) |
Mr. Jeffrey Dierks M.B.A. | Executive VP & Chief Commercial Officer | 662.1k | 1972 (53 years) |
Mr. David Bradshaw | Head of Technical Operations | N/A | |
Mr. Christian Ulrich | General Counsel & Corporate Secretary | N/A | |
Dr. Jeffrey M. Dayno M.D. | President, CEO & Director | 762.15k | 1957 (68 years) |
Mr. Andrew Serafin J.D., M.B.A. | Executive VP & Chief Strategy Officer | 605.42k | 1975 (50 years) |
Ms. Tricia Glover | Chief Compliance Officer | N/A | |
Dr. Kumar Budur M.D., M.S. | Executive VP and Chief Medical & Scientific Officer | ||
Brennan Doyle | VP & Head of Investor Relations | ||
Mr. Sandip S. Kapadia CPA, M.B.A. | Executive VP, Chief Administrative Officer & CFO | 1970 (55 years) |
Address: United States, Plymouth Meeting, PA , 630 West Germantown Pike - open in Google maps, open in Yandex maps
Website: http://www.harmonybiosciences.com
Website: http://www.harmonybiosciences.com